Surmodics | SRDX - Cost Of Sales


Surmodics reported $9.49M in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Align Technology USD 303.5M 60.47M Mar/2026
Anika Therapeutics USD 11.44M 797K Dec/2025
Artivion USD 42.85M 3.86M Dec/2025
Baxter International USD 1.81B 587M Mar/2026
Boston Scientific USD 1.83B 8M Mar/2026
EDAP TMS EUR 7.91M 1.31M Sep/2025
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
Haemonetics USD 136.58M 4.01M Dec/2025
Heron Therapeutics USD 11.12M 795K Dec/2025
J&J USD 8.07B 103M Mar/2026
Merit Medical Systems USD 197.08M 1.5M Mar/2026
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Option Care Health USD 1.1B 98.26M Mar/2026
Stryker USD 2.36B 325M Mar/2026
Surmodics USD 9.49M 23.54M Jun/2025
Trinity Biotech USD 7.84M 3.14M Sep/2025